1. Home
  2. BLBD vs MLTX Comparison

BLBD vs MLTX Comparison

Compare BLBD & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

N/A

Current Price

$56.27

Market Cap

1.9B

ML Signal

N/A

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

N/A

Current Price

$10.81

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLBD
MLTX
Founded
1927
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
BLBD
MLTX
Price
$56.27
$10.81
Analyst Decision
Strong Buy
Buy
Analyst Count
8
15
Target Price
★ $89.13
$28.54
AVG Volume (30 Days)
445.5K
★ 1.9M
Earning Date
11-23-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 22.78
N/A
EPS
★ 7.33
N/A
Revenue
★ $1,480,099,000.00
N/A
Revenue This Year
$18.37
N/A
Revenue Next Year
$14.95
N/A
P/E Ratio
$7.67
★ N/A
Revenue Growth
★ 9.87
N/A
52 Week Low
$46.14
$8.80
52 Week High
$83.39
$23.29

Technical Indicators

Market Signals
Indicator
BLBD
MLTX
Relative Strength Index (RSI) 38.82 29.80
Support Level $53.46 N/A
Resistance Level $64.17 $19.24
Average True Range (ATR) 1.71 0.66
MACD 0.15 0.01
Stochastic Oscillator 31.03 20.60

Price Performance

Historical Comparison
BLBD
MLTX

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: